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. The polyps are usually hamartomas, although adenomas are also seen.
One case of gallbladder polyps in P-J syndrome has been described (Foster & Foster 1980) and one case of a papillary (villous) adenoma of the pancreatic duct associated with bile duct carcinoma and tonisillar carcinoma (Bolwell & James 1979) .
The relationship of P-J syndrome to gastrointestinal carcinoma remains controversial. In 1957 Bartholomew et al. reviewed the literature on the P-J syndrome and concluded that those reports documenting carcinoma arising in P-J syndrome had been misinterpreted. Reid (1974) estimated that 2-3% of patients with the P-J syndrome develop gastrointestinal carcinoma. This figure is probably not significantly different from the normal population. On the other hand, many of those who did develop carcinoma, did so before the age of 40 (Reid 1974 , Perzin & Bridge 1982 , Bussey 1970 . More recently, Linos et al. (1981) reported no evidence of decreased survival among 21 patients with P-J syndrome followed for up to 24 years compared to a matched general population. This was contrary to the Japanese survey by Utsunomiya et al. (1975) . In the most recent review by Perzin & Bridge (1982) their conclusion is that carcinomas may arise within hamartomatous polyps but are possibly preceded by adenomatous change and dysplasia. In our patient it was important to ascertain that there was no evidence of malignancy in the polyps otherwise more radical surgery would have been necessary. In fact, as this was not the case, simple biliary bypass was considered appropriate.
In conclusion, obstructive jaundice occurring in a patient suffering from P-J syndrome may be due. to polyposis of the common bile duct and the authors would recommend percutaneous transhepatic cholangiography as a means of preoperative diagnosis. In the absence of malignant change and in the presence of duodenal polyposis, biliary diversion by means of hepatodochojejunostomy should be employed. A patient with disseminated carcinoma is described who developed cutaneous and systemic features closely resembling those seen in chronic graft-versus-host (GVH) disease. The patient had not received a bone marrow or blood product transplant. The. possibility that a GVH-like reaction was induced by alteration of her 'selfantigens', consequent upon her malignancy, is considered.
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Case report
Mrs E B developed dry eyes' and a dry mouth at the age of 66 years. Reduced lacrimal secretion was confirmed by Schirmer's test. Three weeks later an eruption appeared on her shins composed of erythematous telangiectatic macules. These lesions subsequently became papular and violaceous, resembling lichen planus. There was no improvement in the eruption following the application of topical corticosteroids. Within one month of the onset of her rash she developed ankle oedema, weight loss and diarrhoea. Absorption studies demonstrated that she was malabsorbing and, as a duodenal biopsy showed partial villous atrophy, her malabsorption was attributed to coeliac disease. However, she failed to respond clinically to a gluten-free diet and after 3 months on this diet there was no improvement in her sugar absorption studies.
Over the next 6 months her condition deteriorated. She developed an unexplained intermittent pyrexia, a peripheral neuropathy, polyarthralgia and generalized muscle wasting. It was also noted that she was anaemic with severe thrombocytopenia and a strikingly hypocellular marrow. She was started on prednisolone 40 mg daily which initially produced a clinical improvement with resolution of her pyrexia and improved muscle power. There was also an increase in her platelet count. However, after 3 weeks her condition once more deteriorated with progressive weight loss and profound muscle wasting. There was no improvement on increasing her prednisolone to 60 mg daily, and she died at the age of 67 years.
Investigations: Haemoglobin 9.5 g/dl; platelets 20 x 10 9/1; total white cell count 4.0 x 10 9/1; lymphocytes 1160 x 10 9/1; neutrophils 1920 x 10 9/1; monocytes 440 x 10 9/1; band cells 440 x 10 9/1; eosinophils 40 x 10 9 /1. Circulating lymphocyte surface markers: sheep E rosettes 15%, OKTI 6%, OKT3 7%, OKT4 2%, OKT6 negative, OKT8 negative. OKTIIA 35%, cell surface Ig 3%, TdT negative. The blood film was leukoerythroblastic with many Howell-Jolly bodies. The bone marrow was hypocellular with numerous macrophages which were phagocytosing red cell precursors and platelets. An autoantibody screen demonstrated a thyroid microsomal autoantibody and antinuclear antibody (lgG 1:80, IgM 1:10). Her HLA antigens were AI, A31, B8, B21, DR3. She was anergic on intradermal testing with PPD I: 100, candida, trichophytin and streptococcus. In vitro T-cell studies demonstrated a poor response to the antigens PPD and streptokinase/streptodornase, but normal responses to the mitogens phytohaemagglutinin, pokeweed and concanavalin A. Immunoglobulins G, M, A and E were normal. There was no evidence of circulating immune complexes by Cl, binding or PEG precipitation, and complement studies (C3, C4, CH50) were' normal.
Her liver function was abnormal; bilirubin 23 /lmol/I (normal < 19), alanine transaminase 86 IU/I (normal < 20), alkaline phosphatase 53 King-Armstrong units/dl (normal 2-11), total plasma protein 49 gil (normal 61-77), albumin 26 g/I (normal 41-51). She had no antimitochrondrial antibody. The liver histology showed non-caseating granulomata and increased numbers of mononuclear cells in the portal tracts. In her duodenal biopsy there was partial flattening of the mucosa with a chronic inflammatory infiltrate in the lamina propria..
Skin histopathology:
There was basal cell vacuola-tion with numerous colloid bodies and occasional examples of satellite cell necrosis in the epidermis and a loose mononuclear cell infiltrate in the upper dermis. Direct immunofluorescence (IMF) of lesional skin demonstrated continuous granular deposition of IgA in the papillary dermis and granular C3 at the basement membrane zone (BMZ). Deposition of C3 was also found at the BMZ in skin which appeared normal. Indirect immunofluorescence was negative. On electronmicroscopy of lesional skin there were numerous colloid bodies, some with surrounding 'satellite' mononuclear cells. Langerhans' cells were seen in close association with colloid bodies and occasional1y they appeared to be engulfing them.
At autopsy shewas found to have disseminated carcinoma, but it was not possible to identify the primary neoplasm. It was also noted that she had marked hyposplenism and a goitre.
Discussion
Our patient's rash was clinically and histopathologically very similar to the lichenoid eruption which has been described in chronic GVH disease (Saurat et at. 1975 , Touraine et at. 1975 . The histopathological features which favoured a GVH-like reaction rather than idiopathic lichen planus were the presence of satellite cell necrosis, the considerable number of colloid bodies which were often nucleated and high in the epidermis and the looseness of the infiltrate in the upper dermis (Slavin & Santos 1973) . Similar histopathological features may occasionally be seen in patients taking betablockers (Gange & Levene 1979) or cytotoxic drugs (Cohen et al. 1973) , but neither of these had been prescribed to our patient. IMF examination of our patient's lesional skin showed continuous depostion of IgA in the papillary dermis. Although this appearance is seen in dermatitis herpetiformis, the clinical and histopathological features of the eruption were not compatible with this diagnosis. A further IMF finding in our patient was the deposition of C3 at the BMZ in both lesional and normal-appearing skin. Similar deposition of C3 at the BMZ has also been noted in GVH disease (Ullman et at. 1976 , Tsoi et at. 1978 . In addition to her lichenoid eruption our patient had several other features which have been noted in GVH disease. These included Sjogren's syndrome, small bowel disease, muscle wasting. -marrow 'hypoplasia, hyposplenism, anergy on intradermal skin testing, poor T-cell response to antigens in vitro and the presence of autoantibodies (Schulman et al. 1980) . GVH disease is usually considered to be a disorder exclusive to patients who have received a bone marrow or blood product transplant.
However, it has been suggested that viruses and chemicals may alter self-major histocompatibility structures such that T cells no longer recognize them as self (Gleichmann et al. 1976 ). This view has been supported by clinical and experimental evidence on the role of diphenylhydantoin in the production of autoimmune phenomena (Gleichmann et al. 1979) , and recently a patient has been reported with a syndrome resembling acute GVH disease where the trigger was thought to have been a drug or an infection (Breathnach et al. 1980) . Our patient's illness closely resembled chronic GVH disease yet she had not received a blood product transplant. There was no history of a viral infection preceding her illness. The only drug which she had taken prior to the onset of her symptoms was azapropazone, which has not previously been described in association with GVH-like reactions. Therefore we feel that our patients GVH-like disease was probably the result of alteration in self-antigens consequent upon her disseminated malignancy.
Our patient possessed the HLA antigens B8 and DR3. Batchelor (1980) has suggested that these antigens are markers of high immune responsiveness. In view of this it is possible that patients with B8 and DR3 would be more susceptible to the development of a GVH-Iike reaction on exposure to altered self-antigens.
This case lends support to the suggestion that GVH-like reactions are not simply limited to patients with bone marrow grafts or blood product transfusions but may develop in any situation in which there had been an alteration in self-antigens. Such a change in self-antigens could occur in malignant disease, certain viral infections or exposure to sensitizing drugs. This broader concept of GVH reactions may help us to advance our understanding of the pathogenesis of disorders such as lichen planus, coeliac disease and primary biliary cirrhosis which have overlapping features with GVH disease.
